AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Recruiting

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(16 sites)

United States

Avenzo Therapeutics Recruiting Site, Gilbert, Arizona

Avenzo Therapeutics Recruiting Site, Los Angeles, California

Avenzo Therapeutics Recruiting Site, Denver, Colorado

Avenzo Therapeutics Recruiting Site, New Haven, Connecticut

Avenzo Therapeutics Recruiting Site, Washington D.C., District of Columbia